המרכז הרפואי ת"א ע"ש סוראסקי

1. Toubi E, Kessel A, Rosner I, Rozenbaum M, Paran D, Shoenfeld Y.
    The reduction of serum B-lymphocyte activating factor levels following
    quinacrine add-on therapy in systemic lupus erythematosus.
    Scand J Immunol. 2006 Apr;63(4):299-303.

2. Breuer GS, Orbach H, Elkayam O, Berkun Y, Paran D, Mates M, Nesher G.
    Use of complementary and alternative medicine among patients attending
    rheumatology clinics in Israel.
    Isr Med Assoc J. 2006 Mar;8(3):184-7.

3. Litinsky I, Paran D, Levartovsky D, Wigler I, Kaufman I, Yaron I, Yaron M,
   Caspi D, Elkayam O.
   The effects of leflunomide on clinical parameters and serum levels of IL-6,
   IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis.
   Cytokine. 2006 Jan 21;33(2):106-10. Epub 2006 Feb 17.

4. Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D,
    Litinsky I, Elkayam O.
    Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA
    rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and
    osteoarthritis.
    Arthritis Rheum. 2006 Feb 15;55(1):53-6.

5. Elkayam O, Paran D, Burke M, Zakut V, Ben-Yitshak R, Litinsky I, Caspi D.
    Pneumococcal vaccination of patients with systemic lupus erythematosus: effects
    on generation of autoantibodies.
    Autoimmunity. 2005 Nov;38(7):493-6.

6. Elkayam O, Segal R, Lidgi M, Caspi D.
    Positive anti-cyclic citrullinated proteins and Rheumatoid Factor during active
    lung Tuberculosis.
    Ann Rheum Dis. 2005 Dec 16; [Epub ahead of print]

7. Ben-Ami R, Paran D, Herishanu Y, Elkayam O, Shopin L.
    Venous and arterial thrombosis following administration of intravenous
    immunoglobulins: reply to Feuillet and colleagues.
    Blood Coagul Fibrinolysis. 2005 Nov;16(8):619. No abstract available.

8. Lev-Ari S, Strier L, Kazanov D, Elkayam O, Lichtenberg D, Caspi D, Arber N.
    Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic
    effects of celecoxib in osteoarthritis synovial adherent cells.
   Rheumatology (Oxford). 2006 Feb;45(2):171-7. Epub 2005 Oct 25.

9. Ablin J, Verbovetski I, Trahtemberg U, Metzger S, Mevorach D.
    Quinidine and procainamide inhibit murine macrophage uptake of apoptotic and
    necrotic cells: a novel contributing mechanism of drug-induced-lupus.
    Apoptosis. 2005 Oct;10(5):1009-18.

10.Reitblat T, Litinsky I, Caspi D, Elkayam O.
    Antiphospholipid syndrome and palindromic rheumatism: a new possible
    association.
    Rheumatol Int. 2005 Oct;25(8):595-8. Epub 2004 Jul 23.

11. Breuer GS, Orbach H, Elkayam O, Berkun Y, Paran D, Mates M, Nesher G. Perceived
     efficacy among patients of various methods of complementary
     alternative medicine for rheumatologic diseases.
     Clin Exp Rheumatol. 2005 Sep-Oct;23(5):693-6.

12. Paran D, Chapman J, Korczyn AD, Elkayam O, Hilkevich O, Groozman GB,
      Levartovsky D, Litinsky I, Caspi D, Segev Y, Drory VE.
      Evoked potential studies in the antiphospholipid syndrome: differential
      diagnosis from multiple sclerosis.
      Ann Rheum Dis. 2006 Apr;65(4):525-8. Epub 2005 Aug 17.

13. Giladi M, Maman E, Paran D, Bickels J, Comaneshter D, Avidor B, Varon-Graidy
      M, Ephros M, Wientroub S.
      Cat-scratch disease-associated arthropathy.
      Arthritis Rheum. 2005 Nov;52(11):3611-7.

14. Elkayam O, Burke M, Vardinon N, Zakut V, Yitzhak RB, Paran D, Levartovsky D,
      Litinsky I, Caspi D.
      Autoantibodies profile of rheumatoid arthritis patients during treatment with
      infliximab.
      Autoimmunity. 2005 Mar;38(2):155-60.

15. Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, Levartovsky D,
      Litinsky I, Kaufman I, Wigler I, Mendelson E, Elkayam O.
      Vaccination against influenza in rheumatoid arthritis: the effect of disease
      modifying drugs, including TNF alpha blockers.
      Ann Rheum Dis. 2006 Feb;65(2):191-4. Epub 2005 Jul 13.

16. Paran D, Herishanu Y, Elkayam O, Shopin L, Ben-Ami R.
      Venous and arterial thrombosis following administration of intravenous
      immunoglobulins.
      Blood Coagul Fibrinolysis. 2005 Jul;16(5):313-8.

17. Kaufman I, Caspi D, Yeshurun D, Dotan I, Yaron M, Elkayam O.
The effect of infliximab on extraintestinal manifestations of Crohn's disease.
Rheumatol Int. 2005 Aug;25(6):406-10. Epub 2004 Aug 12.

18. Paran D, Kidron D, Mayo A, Ziv O, Chowers Y, Caspi D, Yaron M, Paran H.
      Somatostatin analogue treatment attenuates histological findings of
      inflammation and increases mRNA expression of interleukin-1 beta in the
      articular tissues of rats with ongoing adjuvant-induced arthritis.
      Rheumatol Int. 2005 Jun;25(5):350-6. Epub 2004 Mar 26.

19. Ablin JN, Aloush V.
     Causes of familial aggregation of fibromyalgia: comment on the article by
     Arnold et al.
     Arthritis Rheum. 2004 Sep;50(9):3059-60; author reply 3060.

20. Elkayam O, Caspi D.
Infliximab induced lupus in patients with rheumatoid arthritis.
Clin Exp Rheumatol. 2004 Jul-Aug;22(4):502-3. Review..

21. Elkayam O, Segal R, Caspi D.
     Human leukocyte antigen distribution in Israeli patients with psoriatic
     arthritis.
     Rheumatol Int. 2004 Mar;24(2):93-7. Epub 2003 Jun 17.

22. Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB.
      The effect of tumor necrosis factor blockade on the response to pneumococcal
      vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
      Semin Arthritis Rheum. 2004 Feb;33(4):283-8.

23. Paran D, Fireman E, Elkayam O.
       Pulmonary disease in systemic lupus erythematosus and the antiphospholpid
       syndrome.
       Autoimmun Rev. 2004 Jan;3(1):70-5.

24. Ben-Ami R, Barshtein G, Mardi T, Deutch V, Elkayam O, Yedgar S, Berliner S.
      A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red
      blood cell aggregation.
      Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2663-9. Epub 2003 Jul 17.

25. Meltzer E, Elkayam O.
      [Caring for illegal immigrants within the public hospital: the need for an
      urgent solution]
      Harefuah. 2003 Jun;142(6):402-4, 488. Hebrew.

26. Lidar M, Elkayam O, Goodwin D, Yaron M, Caspi D.
       Protracted Mycobacterium kansasii carpal tunnel syndrome and tenosynovitis.
       Isr Med Assoc J. 2003 Jun;5(6):453-4. No abstract available.

27. Paran D, Paran H.
      Somatostatin analogs in rheumatoid arthritis and other inflammatory and
      immune-mediated conditions.
      Curr Opin Investig Drugs. 2003 May;4(5):578-82. Review.

28. Elkayam O, Gat A, Lidgi M, Segal R, Yaron M, Caspi D.
Atypical cutaneous findings in a patient with systemic lupus erythematosus.
Lupus. 2003;12(5):413-7.

29. Toubi E, Kessel A, Rosner I, Rozenbaum M, Lorber M, Paran D, Sabo E, Golan
      TD.
      Quinacrine added to ongoing therapeutic regimens attenuates anticardiolipin
      antibody production in SLE.
      Lupus. 2003;12(4):297-301.

30. Segal R, Baumoehl Y, Elkayam O, Levartovsky D, Litinsky I, Paran D, Wigler I, Habot B,
       Leibovitz A, Sela BA, Caspi D.
      Anemia, serum vitamin B12, and folic acid in patients with rheumatoid
      arthritis, psoriatic arthritis, and systemic lupus erythematosus.
      Rheumatol Int. 2004 Jan;24(1):14-9. Epub 2003 Apr 29.

31. Elkayam O, Yaron I, Shirazi I, Judovitch R, Caspi D, Yaron M.
      Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis
      factor alpha, nitric oxide, and metalloproteinase-3 production in activated
      human synovial tissue cultures.
      Ann Rheum Dis. 2003 May;62(5):440-3.

32. Sthoeger ZM, Dayan M, Tcherniack A, Green L, Toledo S, Segal R, Elkayam O,
       Mozes E.
       Modulation of autoreactive responses of peripheral blood lymphocytes of
       patients with systemic lupus erythematosus by peptides based on human and murine
       anti-DNA autoantibodies.
       Clin Exp Immunol. 2003 Feb;131(2):385-92.

33. Elkayam O, Hawkins PN, Lachmann H, Yaron M, Caspi D.
       Rapid and complete resolution of proteinuria due to renal amyloidosis in a
       patient with rheumatoid arthritis treated with infliximab.
       Arthritis Rheum. 2002 Oct;46(10):2571-3.

34. Elkayam O, Yaron M, Caspi D.
       Safety and efficacy of vaccination against hepatitis B in patients with
       rheumatoid arthritis.
      Ann Rheum Dis. 2002 Jul;61(7):623-5.

35. Elkayam O, Paran D, Even-Sapir E, Litinsky I, Wigler I, Yaron M, Caspi D.
      Abdominal scintigraphy using technetium Tc 99m hexylmethylpropylene amine
      oxime-labeled leukocytes in patients with seronegative spondyloarthropathies.
      Semin Arthritis Rheum. 2002 Jun;31(6):406-12.

36. Litinsky I, Elkayam O, Flusser G, Segal R, Yaron M, Caspi D.
Sarcoidosis: TB or not TB?
Ann Rheum Dis. 2002 May;61(5):385-6. No abstract available.

37. Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D, Rubins JB.
       Immunogenicity and safety of pneumococcal vaccination in patients with
       rheumatoid arthritis or systemic lupus erythematosus.
       Clin Infect Dis. 2002 Jan 15;34(2):147-53. Epub 2001 Dec 4.

38. Paran D, Elkayam O, Mayo A, Paran H, Amit M, Yaron M, Caspi D.
       A pilot study of a long acting somatostatin analogue for the treatment of
       refractory rheumatoid arthritis.
       Ann Rheum Dis. 2001 Sep;60(9):888-91.

39. Elkayam O, Caspi D, Flusser G.
Pneumatosis intestinalis in a patient with polymyositis.
Clin Exp Rheumatol. 2001 Jul-Aug;19(4):483. No abstract available.

40. Caspi D, Elkayam O, Eisinger M, Vardinon N, Yaron M, Burke M.
       Clinical significance of low titer anti-nuclear antibodies in early rheumatoid
       arthritis: implications on the presentation and long-term course of the disease.
       Rheumatol Int. 2001 Feb;20(2):43-7.

41. ElKayam O, Yaron M, Caspi D.
       From wheels to feet: a dramatic response of severe chronic psoriatic arthritis
       to etanercept.
      Ann Rheum Dis. 2000 Oct;59(10):839. No abstract available.

42. Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D.
Serum levels of hyaluronic acid in patients with psoriatic arthritis.
Clin Rheumatol. 2000;19(6):455-7.

43. Paran H, Mayo A, Paran D, Neufeld D, Shwartz I, Zissin R, Singer P, Kaplan
      O, Skornik Y, Freund U.
      Octreotide treatment in patients with severe acute pancreatitis.
      Dig Dis Sci. 2000 Nov;45(11):2247-51.

44. Elkayam O, Oumanski M, Yaron M, Caspi D.
Watermelon stomach following and preceding systemic sclerosis.
Semin Arthritis Rheum. 2000 Oct;30(2):127-31. Review.

45. Fusman R, Zeltser D, Rotstein R, Chapman J, Avitzour D, Shapira I I, Eldor
       A, Elkayam O, Caspi D, Arber N, Berliner S.
       INFLAMET: an image analyzer to display erythrocyte adhesiveness/aggregation.
       Eur J Intern Med. 2000 Oct;11(5):271-276.

46. Zelster D, Fusman R, Chapman J, Rotstein R, Shapira I, Elkayam O, Eldor A,
      Arber N, Berliner S.
      Increased leukocyte aggregation induced by gamma-globulin: a clue to the
     presence of pseudoleukopenia.
     Am J Med Sci. 2000 Sep;320(3):177-82.

47. Dayan M, Segal R, Sthoeger Z, Waisman A, Brosh N, Elkayam O, Eilat E,
       Fridkin M, Mozes E.
       Immune response of SLE patients to peptides based on the complementarity
       determining regions of a pathogenic anti-DNA monoclonal antibody.
      J Clin Immunol. 2000 May;20(3):187-94.

48. Elkayam O, Ophir J, Yaron M, Caspi D.
       Psoriatic arthritis: interrelationships between skin and joint manifestations
       related to onset, course and distribution.
       Clin Rheumatol. 2000;19(4):301-5.